Muscle weakness
Fatigue
Weakness that worsens with activity and improves with rest
Visual disturbances such as double vision and droopy eyelids
Difficulty swallowing
Breathing difficulties
Shortness of breath
Myasthenia gravis occurs when the immune system attacks the neuromuscular junction, where nerves communicate with muscles. This attack often involves antibodies targeting the acetylcholine receptor (AChR) or muscle-specific kinase (MuSK), leading to impaired muscle contraction. The exact cause of the immune response is unknown, but factors such as infections and an overactive thymus gland may play a role.
Blood tests to detect antibodies to AChR or MuSK Electromyography (EMG) to evaluate muscle function.
The Tensilon test, which uses a drug to temporarily improve muscle strength.
Imaging of the thymus gland using chest x-rays, CT scans, or MRI.
Immunosuppressive medications: These drugs help to reduce the immune system's activity, minimizing the impact on muscle function.
Plasmapheresis: A procedure that removes harmful antibodies from the blood, providing temporary relief of symptoms.
Intravenous Immunoglobulin (IVIG): This treatment helps to regulate the immune system and can be used during a crisis
Thymectomy: Surgical removal of the thymus gland, which can lead to symptom improvement in some patients.
Symptomatic treatments: Medications such as pyridostigmine can improve muscle function by increasing the amount of acetylcholine available at the neuromuscular junction.
Myasthenia gravis is a manageable condition, and advances in treatment options, such as immunotherapy and targeted therapies, have improved the quality of life for individuals with the disease. Although there is no cure, early diagnosis and proper treatment can significantly help manage symptoms and improve outcomes.